Using a measurement tool called the SCR, researchers found that combining MDMA with fear extinction learning and recall therapy significantly reduced the fear felt by study participants, as compared to the placebo. This may have big implications for how we treat PTSD.
Those caught with under 2.5 grams of illicit drugs, including heroin and fentanyl, will not face jail time when the regulations go into effect.
In today’s episode of PSYCBiz, James, the Psychedelic Investor, sits down with David Harder, Co-CEO of ATMA.
ATMA is a company that is primarily focused on training therapists on how to conduct psychedelic therapy.
The company also has plans to launch psilocybin clinical trials, treat depression patients in Canada under the SAP program, and work with Oregon in their legalization of psilocybin therapy.
This interview took place at the Catalyst Summit, a psychedelic conference that David Harder helped organize. This conference saw big names like Paul Stamets attend.
In the conversation, David and James get philosophical and discuss the nature of psychedelics and consciousness. Topics such as the right to try are also discussed.
To learn more about ATMA, visit: https://www.atmajourney.com/
To learn more about Catalyst, visit: https://catalystpresents.ca/
#psychedelics #therapy #magicmushrooms
Modernized psychedelic medicine is coming, whether you like it or not, so here are five of the most exciting next-generation psychedelics on the horizon.
This week in psychedelic business news: New patents; another Health Canada SAP Approval; and legal psilocybin rules for Oregon.
Famed mycologist Paul Stamets recommends the Stamets Stack when microdosing psilocybin. Here’s how he plans and measures doses.
After leaving the Catalyst Summit, I am more confident than ever in the governmental and regulatory pathways for legal psychedelic medicine.
Oregon Health Authority did not budge on three rules that the public took issue with.
Members of the Psychedelic Spotlight team share their favorite psychedelic books that explore our favorite subject.
The producer and director of our flagship video series “Spotlight in Focus” writes about the parallels between horror and psychedelics.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.